Bisphenol a May Reduce the Efficacy of Androgen Deprivation Therapy in Prostate Cancer

Cancer Causes and Control - Netherlands
doi 10.1007/s10552-009-9337-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Androgen Deprivation Therapy for Prostate Cancer

2017English

Androgen Deprivation Therapy as Backbone Therapy in the Management of Prostate Cancer

OncoTargets and Therapy
OncologyPharmacology
2016English

Evolving Use of Androgen Deprivation Therapy in Prostate Cancer Management

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2016English

Pharmacological Inhibition of the Notch Pathway Enhances the Efficacy of Androgen Deprivation Therapy for Prostate Cancer

International Journal of Cancer
Cancer ResearchOncology
2018English

Androgen Deprivation Therapy for Prostate Cancer and Risk of Dementia

BJU International
Urology
2019English

Use of Androgen Deprivation Therapy in Prostate Cancer: Indications and Prevalence

Asian Journal of Andrology
MedicineUrology
2012English

Androgen Deprivation Therapy for Prostate Cancer—review of Indications in 2010

Current Oncology
Oncology
2010English

Role of Androgen Deprivation Therapy for Node-Positive Prostate Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2009English

Adaptive Phenotype Drives Resistance to Androgen Deprivation Therapy in Prostate Cancer

Cell Communication and Signaling
BiochemistryCell BiologyMolecular Biology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy